Atlas Trials

ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT02523469 · COMPLETED

Trial details

NCT number
NCT02523469
Sponsor
Medical University of South Carolina
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2016-01-08
Primary completion
2023-02-24
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.